Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Frédéric Houssiau
ResearcherPublications, citations & collaboration network
Frédéric Houssiau is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 318 works, 20,236 citations, an h-index of 57 and an i10-index of 124.
318
Works
20,236
Citations
57
h-index
124
i10-index
How has Frédéric Houssiau's publication output changed over time?
ScholarIQpublication output · 1989–2023
Output grew0% over the shown period — from 1 works in 1989 to 1 in 2023.
1
1
1
1
1
1
1
2
1
1
1989199320022012201420162019202020212023
What are the most-cited papers on Frédéric Houssiau?
ScholarIQmost cited works
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Antonis Fanouriakis, Myrto Kostopoulou, Alessia Alunno, Martin Aringer, Ingeborg M. Bajema, John Boletis, Ricard Cervera, Andrea Doria, Caroline Gordon, Marcello Govoni, Frédéric Houssiau, David Jayne, Marios Kouloumas, Annegret Kuhn, J.L. Larsen, Kirsten Lerstrøm, Gabriella Moroni, Marta Mosca, Matthias Schneider, Josef S Smolen, Elisabet Svenungsson, Vladimı́r Tesař, Anǵela Tincani, Anne Troldborg, Ronald van Vollenhoven, Joerg Wenzel, George Βertsias, Dimitrios T. Boumpas
Annals of the Rheumatic Diseases. 20192,032 CitationsOPEN ACCESS
Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide
Frédéric Houssiau, Carlos Vasconcelos, David D’Cruz, Gian Domenico Sebastiani, Enrique de Ramón Garrido, Maria Giovanna Danieli, Daniel Abramovicz, Daniël Blockmans, Alessandro Mathieu, Haner Di̇reskeneli̇, Mauro Galeazzi, Ahmet Gül, Yair Levy, P Petera, Rajko Popović, Radmila Petrović, Renato Alberto Sinico, Roberto Cattaneo, Josep Font, Geneviève Depresseux, Jean‐Pierre Cosyns, Ricard Cervera
S132787887. 20021,077 CitationsOPEN ACCESS
Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
George Βertsias, Maria G. Tektonidou, Zahir Amoura, Martin Aringer, Ingeborg M. Bajema, Jo H. M. Berden, John Boletis, Ricard Cervera, Thomas Dörner, Andrea Doria, Franco Ferrario, Jürgen Floege, Frédéric Houssiau, John P. A. Ioannidis, David Isenberg, Cees G. M. Kallenberg, Liz Lightstone, Stephen D. Marks, Alberto Martini, Gabriela Moroni, Irmgard Neumann, Manuel Praga, Matthias Schneider, Argyre Starra, Vladimı́r Tesař, Carlos Vasconcelos, Ronald van Vollenhoven, Elena Zakharova, Marion Haubitz, Caroline Gordon, David Jayne, Dimitrios T. Boumpas
Annals of the Rheumatic Diseases. 20121,027 CitationsOPEN ACCESS
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
Richard Furie, Brad H. Rovin, Frédéric Houssiau, Ana Malvar, Y K Onno Teng, Gabriel Contreras, Zahir Amoura, Xueqing Yu, Chi-Chiu Mok, Mittermayer B. Santiago, Amit Saxena, Yulia Green, Beulah Ji, C. Kleoudis, Susan W. Burriss, Carly Barnett, David A. Roth
New England Journal of Medicine. 20201,005 CitationsOPEN ACCESS
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, Martin Aringer, Laurent Arnaud, Sang‐Cheol Bae, John Boletis, Ian N Bruce, Ricard Cervera, Andrea Doria, Thomas Dörner, Richard Furie, Dafna D. Gladman, Frédéric Houssiau, Luís Inês, David Jayne, Marios Kouloumas, László Kovács, Chi Chiu Mok, Eric F. Morand, Gabriella Moroni, Marta Mosca, Johanna Mücke, Chetan Mukhtyar, György Nagy, Sandra Navarra, Ioannis Parodis, José María Pego‐Reigosa, Michelle Petri, Bernardo A. Pons‐Estel, Matthias Schneider, Josef S Smolen, Elisabet Svenungsson, Yoshiya Tanaka, Maria G. Tektonidou, Y K Onno Teng, Anǵela Tincani, Edward M Vital, Ronald van Vollenhoven, Chris Wincup, George Βertsias, Dimitrios T. Boumpas
Annals of the Rheumatic Diseases. 2023995 CitationsOPEN ACCESS
Related on ScholarIQ
Cliniques Universitaires Saint-Luc
Institution
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Paper
Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide
Paper
Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
Paper
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
Paper
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Paper